{
  "title": "Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech",
  "itunes:title": "Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech",
  "description": "<p>Bloomberg Markets with Carol Massar and Cory Johnson.\n\nGUEST:\nDavid Nierengarten\nHead of Health Care Equity Research \nWedbush Securities \nDiscussing investing in biotech stocks, inlcuding Blueprint Medicines.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Bloomberg Markets with Carol Massar and Cory Johnson.\n\nGUEST:\nDavid Nierengarten\nHead of Health Care Equity Research \nWedbush Securities \nDiscussing investing in biotech stocks, inlcuding Blueprint Medicines.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:summary": "Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "https://assets.bwbx.io/av/users/iqjWHBFdfxIU/vrGLg.2exDWM/v2.mp3",
  "omny:clipId": "17660afe-5ef8-4263-a64a-ae2b00f65458",
  "pubDate": "Mon, 26 Jun 2017 19:52:53 +0000",
  "itunes:duration": 615,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/bloomberg-markets-nierengarten-on-small-mid-market"
}